News
As the FDA cracks down on compounded GLP-1 drugs like semaglutide and tirzepatide, the market for GLP-1 supplements is taking ...
Receiving a generic version of Ozempic or Wegovy from a compounding pharmacy is normally both easier to access and cheaper.
During oral arguments, the defendants contended that the plaintiffs could not support their allegations that Novo Nordisk and ...
3d
GlobalData on MSNTNF and Renova Health use AI to identify patients for GLP-1 treatmentsTNF Pharmaceuticals and Renova Health are set to use AI and machine learning for the identification of high-risk subjects who ...
3d
News-Medical.Net on MSNBody image concerns drive interest in GLP-1 weight loss drugs, study findsA new study from Rutgers University links higher body dissatisfaction, BMI, and maladaptive weight loss behaviors with ...
2d
News-Medical.Net on MSNWhat’s behind Gen Z’s skepticism about Ozempic and WegovyA U.S. study of over 500 youth aged 14–24 found high awareness but widespread hesitation about using semaglutide for weight ...
Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and ...
Terns Pharmaceuticals, Inc.’s TERN share price has surged by 5.83%, which has investors questioning if this is right time to ...
Eli Lilly and Co. (LLY) emerged as a beacon of optimism last week in a market filled with uncertainty and volatility. Shares ...
Ironwood Pharmaceuticals, Inc.’s IRWD share price has surged by 6.68%, which has investors questioning if this is right time ...
Prescribing of drugs between 2021 and 2023 shifted dramatically for both type 2 diabetes and weight loss for people with ...
Lilly trumpeted positive topline results from ACHIEVE-1 (NCT05971940) showing orforglipron to have met the trial’s primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results